Cardimed Overdosage

Several overdosages with orally administered Nicardipine have been reported. One adult patient allegedly ingested 600 mg of Nicardipine [standard (immediate release) capsules]. and another patient, 2160 mg of the sustained release formulation of Nicardipine. Symptoms included marked hypotension, bradycardia, palpitations, flushing, drowsiness, confusion and slurred speech. All symptoms resolved without sequelae. An overdosage occurred in a one-year-old child who ingested half of the powder in a 30 mg Nicardipine standard capsule. The child remain asymptomatic.
Based on results obtained in laboratory animals, lethal overdose may cause systemic hypotension, bradycardia (following initial tachycardia) and progressive atrioventricular conduction block.
Reversible hepatic function abnormalities and sporadic focal hepatic necrosis were noted in some animal species receiving very large dose of Nicardipine.
For treatment of overdosage, standard measures including monitoring of cardiac and respiratory functions should be implemented. The patient should be positioned so as to avoid cerebral anoxia. Frequent blood pressure determinations are essential. Vasopressors are clinically indicated for patients exhibiting profound hypotension. Intravenous Calcium Gluconate may help reverse the effects of Calcium entry blockade.